Teva Pharmaceutical Indus... (TEVA)
Teva Pharmaceutical Industries Max Pain By Strike
TEVA trades at $18.47, 5.5% above the near-term max pain of $17.5 expiring Aug 29, 2025 (5 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($15-$18.5), indicating stable market expectations. Key magnetic zone at 17 where 10 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Teva Pharmaceutical Industries Max Pain By Expiry
Max pain for TEVA shows stable levels around 17.00, reflecting balanced market expectations. The 21% spread signals divergent expectations across timeframes. Most levels below 18.47 may cap rallies. Strong magnetic level at 17 (10 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 29, 2025 | 17.5 | -0.97 (-5.25%) |
| Sep 5, 2025 | 16.5 | -1.97 (-10.67%) |
| Sep 12, 2025 | 17.5 | -0.97 (-5.25%) |
| Sep 19, 2025 | 17 | -1.47 (-7.96%) |
| Sep 26, 2025 | 17 | -1.47 (-7.96%) |
| Oct 3, 2025 | 18.5 | 0.03 (0.16%) |
| Oct 17, 2025 | 17 | -1.47 (-7.96%) |
| Dec 19, 2025 | 17 | -1.47 (-7.96%) |
| Jan 16, 2026 | 17 | -1.47 (-7.96%) |
| Feb 20, 2026 | 17 | -1.47 (-7.96%) |
| Mar 20, 2026 | 17 | -1.47 (-7.96%) |
| Jun 18, 2026 | 17 | -1.47 (-7.96%) |
| Sep 18, 2026 | 17 | -1.47 (-7.96%) |
| Jan 15, 2027 | 15 | -3.47 (-18.79%) |